Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04595994
Title Selinexor Plus Gemcitabine in Selected Advanced Soft-tissue Sarcoma and Osteosarcoma
Acronym SeliSarc
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Grupo Espanol de Investigacion en Sarcomas
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP


No variant requirements are available.